414 related articles for article (PubMed ID: 26423196)
21. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.
Sheppard HW; Celum C; Michael NL; O'Brien S; Dean M; Carrington M; Dondero D; Buchbinder SP
J Acquir Immune Defic Syndr; 2002 Mar; 29(3):307-13. PubMed ID: 11873082
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of CCR5-Δ32 mutation in a cohort of Saudi stem cell donors.
Alarifi M; Al-Amro F; Alalwan A; Al-Turki A; Fakhoury H; Atallah N; Al-Muallimi M; Al-Balwi M; Alzahrani M; Alaskar A; Hajeer A; Jawdat D
HLA; 2017 Nov; 90(5):292-294. PubMed ID: 28731615
[TBL] [Abstract][Full Text] [Related]
24. Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells.
Verheyen J; Thielen A; Lübke N; Dirks M; Widera M; Dittmer U; Kordelas L; Däumer M; de Jong DCM; Wensing AMJ; Kaiser R; Nijhuis M; Esser S
Clin Infect Dis; 2019 Feb; 68(4):684-687. PubMed ID: 30020413
[TBL] [Abstract][Full Text] [Related]
25. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
[TBL] [Abstract][Full Text] [Related]
26. [HIV: vision of a cure].
Boffi el Amari E
Rev Med Suisse; 2011 Oct; 7(312):1968, 1970-3. PubMed ID: 22097447
[TBL] [Abstract][Full Text] [Related]
27. CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy.
Henrich TJ; Hanhauser E; Harrison LJ; Palmer CD; Romero-Tejeda M; Jost S; Bosch RJ; Kuritzkes DR
J Infect Dis; 2016 Mar; 213(5):766-70. PubMed ID: 26512140
[TBL] [Abstract][Full Text] [Related]
28. Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS.
Esmaeilzadeh A; Farshbaf A; Erfanmanesh M
Med Hypotheses; 2015 Mar; 84(3):216-8. PubMed ID: 25613565
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic stem cell transplantation for HIV cure.
Kuritzkes DR
J Clin Invest; 2016 Feb; 126(2):432-7. PubMed ID: 26731468
[TBL] [Abstract][Full Text] [Related]
30. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
Tebas P; Jadlowsky JK; Shaw PA; Tian L; Esparza E; Brennan AL; Kim S; Naing SY; Richardson MW; Vogel AN; Maldini CR; Kong H; Liu X; Lacey SF; Bauer AM; Mampe F; Richman LP; Lee G; Ando D; Levine BL; Porter DL; Zhao Y; Siegel DL; Bar KJ; June CH; Riley JL
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571163
[TBL] [Abstract][Full Text] [Related]
31. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
32. Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.
Wang C; Abdel-Mohsen M; Strain MC; Lada SM; Yukl S; Cockerham LR; Pilcher CD; Hecht FM; Sinclair E; Liegler T; Richman DD; Deeks SG; Pillai SK
J Infect Dis; 2014 Dec; 210(11):1838-43. PubMed ID: 24935955
[TBL] [Abstract][Full Text] [Related]
33. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
Gastroenterology; 2002 Jun; 122(7):1721-8. PubMed ID: 12055576
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic expressions of CCR5-delta32/delta32 homozygosity.
Nguyêñ GT; Carrington M; Beeler JA; Dean M; Aledort LM; Blatt PM; Cohen AR; DiMichele D; Eyster ME; Kessler CM; Konkle B; Leissinger C; Luban N; O'Brien SJ; Goedert JJ; O'Brien TR
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):75-82. PubMed ID: 10534150
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
Takácová M; Nogová P; Hábeková M; Staneková D
Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
[TBL] [Abstract][Full Text] [Related]
36. From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation.
Prator CA; Donatelli J; Henrich TJ
Curr HIV/AIDS Rep; 2020 Aug; 17(4):385-393. PubMed ID: 32519184
[TBL] [Abstract][Full Text] [Related]
37. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.
Salgado M; Gálvez C; Nijhuis M; Kwon M; Cardozo-Ojeda EF; Badiola J; Gorman MJ; Huyveneers LEP; Urrea V; Bandera A; Jensen BO; Vandekerckhove L; Jurado M; Raj K; Schulze Zur Wiesch J; Bailén R; Eberhard JM; Nabergoj M; Hütter G; Saldaña-Moreno R; Oldford S; Barrett L; Ramirez MLM; Garba S; Gupta RK; Revollo B; Ferra-Coll C; Kuball J; Alter G; Sáez-Cirión A; Diez-Martin JL; Duke ER; Schiffer JT; Wensing A; Martinez-Picado J;
Lancet HIV; 2024 Jun; 11(6):e389-e405. PubMed ID: 38816141
[TBL] [Abstract][Full Text] [Related]
38. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
39. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
Pippi F
Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]